EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral Sodium Hyaluronate Reshapes Gut Microbiota Composition and Suppresses the LPS-TLR4/NF-κB Pathway to Exert Neuroprotection in MPTP-Induced Parkinson’s Disease

Yishu Wang iD, Zhi Cao iD, Chao Zhang, Yong Ying, Gaofei Zhu, Jie Wang, Xinyu Hou, Daizhou Zhang, Zhiyong Zheng, Huarong Shao, Fei Liu, Xiaodong Ma

International Journal of Molecular Sciences · 23.07.2026 · 27 (15) · 6573

DOI: 10.3390/ijms27156573 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.07.2026. Verfasst von Yishu Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Brain, Cognition and Education Sciences, Ministry of Education, Institute for Brain Research and Rehabilitation, South China Normal…. Hauptthemen laut MEDLINE: Hyaluronic Acid, Toll-Like Receptor 4, NF-kappa B, Gastrointestinal Microbiome. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, Shandong Province Key R&D Program, Shandong Institute of Advanced Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD), a debilitating neurodegenerative disorder, is primarily characterized by motor impairments and concurrent gastrointestinal disturbances. Increasing evidence has highlighted the critical role of the microbiota–gut–brain axis (MGBA) in the pathogenesis of PD. This study investigated the neuroprotective potential of sodium hyaluronate (SH) in a mouse model of PD and its underlying mechanisms via the MGBA. In the oral pre-treatment study, three doses (7.5, 15, and 30 mg/kg/day) were evaluated. The results showed that the high dose (SH-H, 30 mg/kg/day) significantly ameliorated motor disorders and gastrointestinal functional disorders. Therefore, SH-H was selected for subsequent mechanistic investigations. Mechanistically, SH-H restored gut microbiota homeostasis, increased fecal short-chain fatty acid (SCFA) levels, and improved the integrity of the intestinal and blood–brain barrier (BBB). Thus, SH reduced the transfer of lipopolysaccharide (LPS) from the intestine to serum and the substantia nigra (SN), suppressing activation of the LPS-TLR4/MyD88/NF-κB signaling pathway. These effects alleviated neuroinflammation, protected dopaminergic neurons, and reduced the aggregation of α-synuclein (α-syn). In summary, SH attenuated PD-related pathological changes by restoring gut microbiota homeostasis and modulating the MGBA, suggesting that SH may represent a potential therapeutic strategy for PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronic AcidToll-Like Receptor 4NF-kappa BGastrointestinal MicrobiomeNeuroprotective AgentsLipopolysaccharidesParkinson DiseaseAnimalsMiceSignal TransductionMaleAdministration, OralDisease Models, AnimalMice, Inbred C57BLNeuroprotection

Stichwörter der Autor:innen

Parkinson’s diseasemicrobiota–gut–brain axisneuroinflammationneuroprotectionsodium hyaluronate

Substanzen

Hyaluronic AcidToll-Like Receptor 4NF-kappa BNeuroprotective AgentsLipopolysaccharidesTlr4 protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Brain, Cognition and Education Sciences, Ministry of Education, Institute for Brain Research and Rehabilitation, South China Normal University, Guangzhou 510631, China.
  • Shandong Academy of Pharmaceutical Sciences, Engineering Research Center for Sugar and Sugar Complex, National-Local Joint Engineering Laboratory of Polysaccharide Drugs, Key Laboratory of Carbohydrate and Glycoconjugat…
  • The Second Clinical Medical College, Jinan University, Shenzhen 518020, China.
  • College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.

ORCID-Profile: Yishu Wang, Zhi Cao

Förderung

  • National Key Research and Development Program
  • Shandong Province Key R&D Program
  • Shandong Institute of Advanced Technology
  • Shenzhen University Health Science Center
  • National Natural Science Foundation of China
  • Shandong Province Key R&D Program

Zitieren

APA

Wang, Y., Cao, Z., Zhang, C., Ying, Y., Zhu, G., Wang, J., Hou, X., Zhang, D., Zheng, Z., Shao, H., Liu, F., & Ma, X. (2026). Oral Sodium Hyaluronate Reshapes Gut Microbiota Composition and Suppresses the LPS-TLR4/NF-κB Pathway to Exert Neuroprotection in MPTP-Induced Parkinson’s Disease. International Journal of Molecular Sciences, 27(15), 6573. https://doi.org/10.3390/ijms27156573

Vancouver

Wang Y, Cao Z, Zhang C, Ying Y, Zhu G, Wang J, et al. Oral Sodium Hyaluronate Reshapes Gut Microbiota Composition and Suppresses the LPS-TLR4/NF-κB Pathway to Exert Neuroprotection in MPTP-Induced Parkinson’s Disease. International Journal of Molecular Sciences. 2026;27(15):6573. doi:10.3390/ijms27156573

BibTeX
@article{Wang2026,
  author = {Wang, Yishu and Cao, Zhi and Zhang, Chao and Ying, Yong and Zhu, Gaofei and Wang, Jie and Hou, Xinyu and Zhang, Daizhou and Zheng, Zhiyong and Shao, Huarong and Liu, Fei and Ma, Xiaodong},
  title = {Oral Sodium Hyaluronate Reshapes Gut Microbiota Composition and Suppresses the LPS-TLR4/NF-κB Pathway to Exert Neuroprotection in MPTP-Induced Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6573},
  doi = {10.3390/ijms27156573}
}
Kostenlos starten →